Introduction: The wholesale FOXO4 DRI peptide selectively induces apoptosis in senescent cells by disrupting FOXO4-p53 binding, offering steady, high-purity components for growing older and most cancers investigation. Daily laboratory workflows usually reveal a persistent obstacle: the gradual and inefficient removal of senescent cells that impair